Shareholders of Bide Pharmaceutical (688073.SH) plan to reduce their total holdings by no more than 3%

Zhitong Finance App News, Bide Pharmaceutical (688073.SH) issued an announcement. Due to shareholders' own liquidity needs, shareholders Xinxi Management, Landan Management, and Mr. Wu Bo, their co-actor, plan to reduce their holdings of the company through centralized bidding and bulk transactions within 3 months after 15 trading days from the date of disclosure of this holdings reduction plan according to market conditions. Among them, Xinxi Management plans to reduce the number of company shares by no more than 1.0361 million shares, that is, no more than 1.14% of the company's total share capital, and reduce the number of company shares by no more than 363,500 shares, or 0.40% of the company's total share capital through centralized bidding; Landan Management plans to reduce the number of company shares by no more than 781,600 shares, that is, no more than 0.86% of the company's total share capital through centralized bidding; shareholder Wu Bo It is proposed to reduce the number of company shares held by no more than 181,800 shares through centralized bidding transactions, that is, no more than 0.20% of the company's total share capital. The price of the holdings reduction will be determined according to the market price at the time the holdings reduction is actually implemented.